Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.98 USD | +0.68% | +4.56% | -29.05% |
May. 16 | First Wave BioPharma, Inc.(NasdaqGM:ENTO) dropped from NASDAQ Composite Index | CI |
May. 10 | First Wave BioPharma, Inc. announced a financing transaction | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.05% | 6.04M | |
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B |
- Stock Market
- Equities
- FWBI Stock
- News Entero Therapeutics, Inc.
- AzurRx BioPharma : HC Wainwright Adjusts Price Target on AzurRx BioPharma to $2.50 From $3.50, Maintains Buy Rating